Ac3IV

N/A

Report date: 2025/03/14 18:11:39

Base Information

Drug NameAc3IV
Drug Alias NameV1a/V1b receptor-specific arginine vasopressin analog (Ulster University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVasopressin V1b receptor agonistsVasopressin V1a receptor agonists
TargetsVasopressin V1b receptorVasopressin V1a receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Ulster
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Ulster
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A